---
title: "Sorafenib - Renal Cell Carcinoma"
sidebar: mydoc_sidebar
permalink: db00398-mesh-d002292-1.html
toc: false 
---


Path ID: `DB00398_MESH_D002292_1`
{% include image.html url="images/db00398-mesh-d002292-1.png" file="db00398-mesh-d002292-1.png" alt="db00398-mesh-d002292-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C471405">MESH:C471405 </a> | Sorafenib | Drug |
| <a href="https://identifiers.org/InterPro:IPR011009">InterPro:IPR011009 </a> | Protein kinase-like domain superfamily | GeneFamily |
| <a href="https://identifiers.org/UniProt:P04049">UniProt:P04049 </a> | RAF proto-oncogene serine/threonine-protein kinase | Protein |
| <a href="https://identifiers.org/UniProt:P09619">UniProt:P09619 </a> | Platelet-derived growth factor receptor beta | Protein |
| <a href="https://identifiers.org/UniProt:P17948">UniProt:P17948 </a> | Vascular endothelial growth factor receptor 1 | Protein |
| <a href="https://identifiers.org/UniProt:P15056">UniProt:P15056 </a> | Serine/threonine-protein kinase B-raf | Protein |
| <a href="https://identifiers.org/UniProt:P35916">UniProt:P35916 </a> | Vascular endothelial growth factor receptor 3 | Protein |
| <a href="https://identifiers.org/UniProt:P35968">UniProt:P35968 </a> | Vascular endothelial growth factor receptor 2 | Protein |
| <a href="https://identifiers.org/UniProt:P36888">UniProt:P36888 </a> | Receptor-type tyrosine-protein kinase FLT3 | Protein |
| <a href="https://identifiers.org/UniProt:P10721">UniProt:P10721 </a> | Mast/stem cell growth factor receptor Kit | Protein |
| <a href="https://identifiers.org/UniProt:P11362">UniProt:P11362 </a> | Fibroblast growth factor receptor 1 | Protein |
| <a href="https://identifiers.org/UniProt:P07949">UniProt:P07949 </a> | Proto-oncogene tyrosine-protein kinase receptor Ret | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-9006934">reactome:R-HSA-9006934 </a> | Signaling by Receptor Tyrosine Kinases | Pathway |
| <a href="https://identifiers.org/GO:0008284">GO:0008284 </a> | Positive regulation of cell population proliferation | BiologicalProcess |
| <a href="https://identifiers.org/GO:0045766">GO:0045766 </a> | Positive regulation of angiogenesis | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D002292">MESH:D002292 </a> | Renal cell carcinoma | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Sorafenib | DECREASES ACTIVITY OF | Protein Kinase-Like Domain Superfamily |
| Protein Kinase-Like Domain Superfamily | POSITIVELY CORRELATED WITH | Raf Proto-Oncogene Serine/Threonine-Protein Kinase |
| Protein Kinase-Like Domain Superfamily | POSITIVELY CORRELATED WITH | Platelet-Derived Growth Factor Receptor Beta |
| Protein Kinase-Like Domain Superfamily | POSITIVELY CORRELATED WITH | Vascular Endothelial Growth Factor Receptor 1 |
| Protein Kinase-Like Domain Superfamily | POSITIVELY CORRELATED WITH | Serine/Threonine-Protein Kinase B-Raf |
| Protein Kinase-Like Domain Superfamily | POSITIVELY CORRELATED WITH | Vascular Endothelial Growth Factor Receptor 3 |
| Protein Kinase-Like Domain Superfamily | POSITIVELY CORRELATED WITH | Vascular Endothelial Growth Factor Receptor 2 |
| Protein Kinase-Like Domain Superfamily | POSITIVELY CORRELATED WITH | Receptor-Type Tyrosine-Protein Kinase Flt3 |
| Protein Kinase-Like Domain Superfamily | POSITIVELY CORRELATED WITH | Mast/Stem Cell Growth Factor Receptor Kit |
| Protein Kinase-Like Domain Superfamily | POSITIVELY CORRELATED WITH | Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret |
| Protein Kinase-Like Domain Superfamily | POSITIVELY CORRELATED WITH | Fibroblast Growth Factor Receptor 1 |
| Serine/Threonine-Protein Kinase B-Raf | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Vascular Endothelial Growth Factor Receptor 3 | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Vascular Endothelial Growth Factor Receptor 2 | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Receptor-Type Tyrosine-Protein Kinase Flt3 | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Mast/Stem Cell Growth Factor Receptor Kit | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Fibroblast Growth Factor Receptor 1 | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Raf Proto-Oncogene Serine/Threonine-Protein Kinase | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Platelet-Derived Growth Factor Receptor Beta | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Vascular Endothelial Growth Factor Receptor 1 | PARTICIPATES IN | Signaling By Receptor Tyrosine Kinases |
| Signaling By Receptor Tyrosine Kinases | CONTRIBUTES TO | Positive Regulation Of Cell Population Proliferation |
| Signaling By Receptor Tyrosine Kinases | CONTRIBUTES TO | Positive Regulation Of Angiogenesis |
| Positive Regulation Of Cell Population Proliferation | CAUSES | Renal Cell Carcinoma |
| Positive Regulation Of Angiogenesis | CAUSES | Renal Cell Carcinoma |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00398](https://go.drugbank.com/drugs/DB00398)
